This paper summarizes the developmental stages of the baboon during the period of organ formation and provides comparative information for other primates, including the human. Special attention is directed to the early development of the nervous system, eye, ear and nose/palate. The similarity in development of these structures with humans indicates that the baboon is a suitable model for studies of normal and abnormal neurological development. Spontaneous prenatal loss rates in the baboon (2.4-11.2%) are slightly lower than those reported in rhesus and cynomologus monkeys. The baboon, in addition to the cynomologus monkey and macaque, has been used as a model in teratology research to assess the potential risk of thalidomide, sex steroids, Bendectin and rubella virus, as well as to study the pathogenesis of malformations associated with the corticosteroid triamcinolone acetonide. The rate of spontaneous malformations (<1%) in baboons, similar to that reported for other commonly used primates, supports their continued use as a teratological model. In this regard, a sample protocol is provided for the safety evaluation of biotechnology products using nonhuman primates, which are the most appropriate model for those compounds which are bioactive in species closely related to humans.
Introduction
Studies of embryonic development in the baboon (Papio sp.) were first reviewed by Hill (1932) . Subsequent studies were carried out by Gilbert and Heuser (1954) , Schuster (1965) , and Boyden (1967) in P. ursinus, P. doguera, P. cynocephalus and P. anubis respectively. Zuckerman (1963) provided an excellent history of nonhuman primates in biomedical history for the first half of the 20th century. His account credits Galen of Pergamen, who based descriptions of human anatomy on baboons and other primates.
The importance of basic studies in development have not diminished with time; in fact there has been a resurgence in embryology research with the steady influx of new molecular technologies that have enabled us to probe developmental events at the subcellular level. Studies in primates are advocated on the basis of their phylogenetic relatedness to humans, as reflected in anatomical, reproductive, genetic/molecular, immunological and embryological/teratological similarities Hendrickx and Binkerd, 1990) . Their use in applied studies has also increased from the past, when they were used primarily as an additional test species to the more commonly used rodents (Wilson, 1973) . For the majority of biotechnology products intended for human use, nonhuman primates are the only species used for safety assessment because these products are bioactive only in species closely related to humans (Trown et al., 1986; Henck et al., 1996) .
Embryology
Division of the developmental process into a series of stages has been a useful method for studying embryology. The developmental staging of the human embryos in the Carnegie Collection, introduced by Streeter (1942 Streeter ( , 1945 Streeter ( , 1948 Streeter ( , 1951 and Heuser and Corner (1957) , was greatly expanded upon by O'Rahilly (1972 O'Rahilly ( , 1979 and O'Rahilly and Gardner (1971) and revised by O'Rahilly and Müller (1987). Developmental staging of embryos undergoing organogenesis incorporates four major criteria, i.e. external and internal morphological features, greatest or crownrump length and fertilization age (conception), to establish each critical period of development. These criteria, established for human embryos and adapted for baboon embryos (Hendrickx, 1971a) , are summarized in Table I .
Description of stages 8-23 (period of organogenesis)
The development of external form as well as the histological ontogeny of several organ systems, including the brain and spinal cord, eye, ear, nose and palate is described in this section for each sequential stage.
Stage 8 ( Figure 1A) The primary features of embryos at this stage are the presence of a neural groove, primitive node and primitive groove. The primitive node, situated near the middle of the embryonic disc, marks the cranial end of the primitive streak which extends caudally. The notochordal process extends to the cranial end of the disc. All of these midline structures are visible in the dorsal external view of the embryo, which resembles a pear-shaped disc. During stage 9, the neural folds and groove are distinct, producing obvious head and caudal folds externally. The primitive streak occupies one-third to one-fourth the length of the embryo. Somites appear as condensations of the paraxial mesoderm lateral to the neural folds near the cephalic end of the notochord. Each somite is set off by an intersomitic groove, a slightly depressed area between each somite. A slight dorsal flexure develops in the somite region.
Stage 10 ( Figure 1C )
Stage 10 embryos are characterized by a more cylindrical, elongated shape which results from the initiation of fusion of the neural folds to form the neural tube. Fusion of the neural folds occurs first between the 4th and 8th somites, which flank the folds in the medial region of the longitudinal axis. The optic primordia appear as bulges in the cranial-most region of the neural folds and the otic placodes are recognized as slight plate-like depressions of the surface ectoderm on each side of the developing hindbrain. The 1st (mandibular) and 2nd (hyoid) pharyngeal arches appear and the heart forms a distinct bulge which is visible ventrally. The cranial (cephalic) flexure is prominent and the trigeminal and otic prominences appear as two dorsolateral thickenings caudal to the flexure.
Stage 11 ( Figure 1D )
At stage 11, the neural tube and folds extend the entire length of the embryo and the cranial (anterior) neuropore is closing or closed, while the caudal neuropore is still apparent. The cervical flexure is detectable and both the optic vesicle and the slightly invaginated otic pits are distinct. The first two pharyngeal arches are well defined and the S-shaped loop of the developing heart is visible. A dorsal flexion of the body also occurs as the embryo becomes elevated above the yolk sac, while the broad communication between the vitelline sac, foregut and hindgut persists.
Stage 12 ( Figure 1E )
The C-shaped curvature of embryos at stage 12 distinguishes them from embryos of the previous stage. The three primary subdivisions of the brain, prosencephalon (forebrain), mesencephalon (midbrain) and rhombencephalon (hindbrain), are recognizable and the thin roof the rhombencephalon is faintly visible. The optic vesicles appear as opaque circles with transparent centres and the otic pit is in the process of closing. There are three distinct pharyngeal arches separated by three pharyngeal grooves. A slight depression, the cervical sinus, appears in the caudal portion of the arch region. The heart bulge is very prominent and the primordium of the forelimb bud becomes apparent at the level of somites 8-13. The caudal neuropore is either in the process of closing or closed.
Stage 13
As the cervical flexure develops, there is a flattening in the upper cervical region. The sacral flexure and curvature of the trunk are also more extensive. The anterior subdivision of the forebrain, the telencephalon, expands slightly, and the roof of the rhombencephalon becomes thinner. The 1st pharyngeal arch is subdividing into maxillary and mandibular processes and the cervical sinus has deepened, but four pharyngeal arches and grooves remain visible. The otocyst is completely closed and is separating from the overlying ectoderm. The tip of the forelimb bud is beginning to curve ventrally and the primordium of the hindlimb bud appears.
Stage 14
The shape of the embryo is angular owing to well-defined cervical and sacral flexures. The rostral area of the embryo is in close contact with the heart bulge and the developing cerebral hemispheres and mesencephalon can be identified. The maxillary process is beginning to swell and both lens and olfactory placodes are visible. The endolymphatic diverticulum becomes apparent as a conical projection dorsal to the otocyst which appears as a clear vesicle aligned with the 2nd pharyngeal arch. The deep cervical sinus conceals the 3rd and 4th pharyngeal arches. The trigeminal ganglion is a large dense area dorsal to the 1st arch and the smaller facioacoustic primordium is less defined at the cranial aspect of the otocyst. The forelimb buds, located opposite somites 7-13, are slightly elongated and curve ventromedially. The hindlimb buds are visible as small swellings at the level of somites 27-30.
Stage 15 (Figure 2A) The body of the embryo is becoming more C-shaped as the cervical flexure becomes more prominent as it attains nearly a 90° angle. Pigmentation of the retina and the nasal pits are first detectable externally. The cerebral hemispheres have expanded prominently and the roof of the posterior portion of the hindbrain (myelencephalon) flattens. The vagus and spinal accessory nerves can now be clearly distinguished. Both the forelimb and hindlimb buds elongate, and slight differentiation of the forelimb bud into a distal hand segment and a proximal arm-shoulder segment takes place.
Stage 16
The trunk of the stage 16 embryo is slightly curved and dominated by an acute cervical flexure angle. The retinal pigmentation is more distinct and the nasal pits face ventrally as the lateral nasal processes develop. Both mandibular and maxillary processes are prominent, and the auditory hillocks are recognizable on the second (hyoid) pharyngeal arch. The cervical sinus has closed, concealing the 3rd and 4th pharyngeal arches. The distal segment of the arm bud is beginning to form a crescentic flange, the primordium of the digital plate.
Stage 17 ( Figure 2B )
Although the trunk of the stage 17 embryo is straighter than that of the previous stage, the cervical flexure is still acute.
The nasal pits open towards the front and the enlarged maxillary arch extends ventromedially. The auricular hillocks consist of six elevations, three on the surface of the mandibular arch and three on the hyoid arch. In the hand, the finger rays are becoming visible and the rim of the plate shows signs of crenation. The leg bud consists of a rounded foot plate and leg/thigh regions.
Stage 18
The trunk region continues to straighten and the head is beginning to move upward, decreasing the cervical angle. The upper and lower eyelids are making their appearance and the nose is set off from the forehead by the frontonasal angle. The prominent auricular hillocks are merging to form the auricle. Distinct finger rays are present in the hand plates with interdigital notches (crenations) on their rims. Toe rays appear in the foot plate but there is no sign of crenation. The forelimbs have moved upward and partially cover the face, and the axes of both the arms and the legs are almost perpendicular to the dorsal line of the body. Arms and legs are rotated in a medial direction so that the palmar surfaces face mediocaudally, while the plantar surfaces face medially and slightly cranially.
Stage 19 ( Figure 2C )
The cervical angle becomes less acute as the head starts to elevate. The upper jaw protrudes beyond the plane of the forehead and the coalescing auricular hillocks are less distinct. Epithelial plugs appear in the external nares that are well formed and open laterally. Constrictions at the elbow and wrist divide the forelimb into arm, forearm and hand, and there is some bending at the elbow. The palmar surfaces of the hand point caudomedially and the interdigital notches are distinct. Digital rays are prominent in the foot plate.
Stage 20
The trunk lengthens and straightens with continued lifting of the head. Blending of the premaxilla and maxilla produces a smoother facial contour at stage 20 than at previous stages. The auricular hillocks have joined into one mass which surrounds the external auditory meatus. Eyelids cover approximately one-fifth of the developing eyes. The fore-and hindlimbs lengthen, with the bends at the wrist and elbow becoming more pronounced. The hands are more medial in position, located just lateral to the nose and ventral to the heart, with the palms directed more caudally. The interdigital notches of the foot are present.
Stage 21 ( Figure 2D )
The cervical angle is >90° and the forehead and neck are more defined. The upper and lower jaws elongate at the same rate, but the upper jaw remains further extended. The eyelids cover approximately one-fourth of the developing eyes. With decrease of the interdigital tissue, the fingers become longer and closer together. The toes become more evident as the interdigital notches of the foot deepen.
Stage 22
Jaw protrusion is evident at this stage, with the lower jaw growing more rapidly than the upper jaw. The eyes are rotated to the front of the face and the thickening eyelids cover approximately one-third of the eyes. The tragus and antitragus are apparent in a more definitive auricle. With additional lengthening of the limbs, the fingers on one side overlap those on the other side, and the feet move closer together. Touch pads appear as slightly raised areas on the terminal phalanges of the fingers.
Stage 23
The neck is extended and the head is elevated from the chest. More definite contours appear in the face as the lower jaw protrudes almost as far as the upper jaw and the auricle is assuming its definitive shape. The forehead is prominent, and the eyelids cover most or all of the eyes. The arms have lengthened considerably, and the hands overlap in front of the face with the palms pointed mostly caudally. The plantar surfaces of the feet face each other, with the tail between, and the distal phalanges of the toes are separated.
Nervous system (stages 8-16)
In the cephalic region at stage 8, the neural plate is the first visible sign of the developing nervous system. The rostrocaudal axis is well defined, with the prochordal plate evident in cranial regions. The notochordal plate and process, which are fused with the endoderm, extend from the prochordal plate to the primitive streak. The latter structure occupies approximately one-half of the embryonic length and terminates at the cloacal membrane. During stage 9, the neural folds flank the longitudinal axis of the embryonic disc. Early in stage 10 the neural tube is formed, converting the disk-like embryonic shield into an elongated cylindrical shape. Closure first takes place between somites 4 and 8 and progresses cranially and caudally at nearly the same rate. The cranial neuropore closes in stage 11, and the caudal neuropore closes in stage 12. The primary brain vesicles, i.e. prosencephalon, mesencephalon and rhombencephalon, appear in stage 10. Neural crest cells contributing to the trigeminal and facioacoustic ganglia are also emigrating from the preotic rhombencephalon at this stage. In the subsequent stage (11) the glossopharyngeal-vagal crest emigrates from the post-otic rhombencephalon. Rhombomeres are becoming distinguishable at stage 11, and thinning of the roof of the rhombencephalon begins during stage 12. The telencephalic area appears as a dorsal outgrowth of the prosencephalon during stage 13; the boundary of the telencephalon and diencephalon are not yet distinguishable. The rhombencephalon is characterized by its very thin roof and seven prominent rhombomeres in its floor. At stage 14 the telencephalon expands rapidly, presaging the distinct formation of the cerebral vesicles in the subsequent stage. Primordia of the epithalamus, dorsal thalamus, ventral thalamus and hypothalamus appear as thickenings demarcated by dorsal and ventral sulci in the lateral walls of the diencephalon. The mesencephalon also shows a rapid increase in size and is subdivided into alar and basal plates by the sulcus limitans. A slight marginal zone appears in the tectum, which is beginning to differentiate. The area of the basis pedunculi of the tegmentum begins to enlarge and has marked neuroblastic proliferation medial to it. The pontine flexure is prominent in the rhombencephalon and the pons area enlarges as the pyramidal tract area forms. Each of the cranial neural crest in the rhombencephalon has transformed into distinct cranial nerves which develop both motor and sensory neurons.
During stages 15 and 16, the cerebral hemispheres become distinct vesicles. The olfactory fila make contact with the olfactory bulb area in the ventrolateral surface of the vesicles. The medial striatal ridge (medial ventricular ridge) appears as a thickening in the basal part of the telencephalic wall. A primordial epiphysis can be recognized in the roof of the telencephalon. The mesencephalon comprises two thin-walled neuromeres with wide lumina. Rootlets of nerves VII, IX and X are distinct. Decussating fibres of the trochlear nerve (IV) are present dorsally at the junction between the caudal neuromere and the metencephalon. Both the basal and alar plates of the metencephalon have widened and constitute the rhombic lips which define the area of the cerebellum. The primordial gyrus dentatus and cornu Ammonis of the hippocampal formation also appear in stages 15 and 16. A rapid cellular proliferation also appears in the mammillary body during this time.
Eye (optic vesicle, stages 10-23)
The optic primordia appear in the cranial-most region of the neural folds during stage 10, and by stage 11 the optic vesicles are formed as evaginations of the lateral walls of the forebrain. The vesicle is very close to, but separated from, the surface epithelium by a thin layer of mesenchyme. During stage 12 the optic vesicle and cavity, which communicate widely with the ventricle of the forebrain, are enlarged. The placodes of the lens appear as thickenings of the surface ectodermal epithelium during stage 13. By stage 14 the optic cup is invaginated and comprises a double-layered structure with a thick inner layer (future neural retina) and thin outer layer (future retinal pigment epithelium). The optic stalk, which separates the optic cup from the brain wall, is apparent by stage 15, and the first indication of pigmentation is evidenced as small brown granules in the outer layer of the optic cup near the rim. During this stage, the lens pit is in the process of closing, or is closed, and remains in contact with the surface epithelium. The restored surface epithelium constitutes the anter-ior epithelium of the future cornea. During stage 16 the lens vesicle, containing early lens fibres, is separated from the surface epithelium by a thick mesenchymal sheath.
The lens body contains longer, more distinct fibres and the lens cavity decreases in size and becomes crescentic during stages 17 and 18. The developing eyelids first appear at stage 19 and the inner neural and outer pigmented layers of the optic cup become more distinct. The cornea continues to differentiate such that by stage 20 these mesodermal cells become organized into a discrete layer which is continuous peripherally with the scleral condensation. Three corneal layers can be identified in stage 21 embryos, as well as the anterior chamber between the cornea and the thin pupillary membrane. In stage 22 embryos the sclera is a discrete layer subjacent to the pigmented retina. The optic canal gradually disappears as it transforms into a very prominent optic nerve by stage 23. At this stage, the eyelids almost completely cover the eye and begin to fuse at the periphery of the eye.
Ear (otic vesicle, stages 10-23)
The otic placodes appear as indistinct ectodermal thickenings early in stage 10 adjacent to the future rhombencephalon. The placodes thicken and begin to invaginate to form the otic pit early in stage 11 and are cup-shaped late in stage 12. During stage 13 the otic vesicles (otocysts) close and detach from the superficial epithelium and remain connected via an ectodermal stalk. A rudimentary endolymphatic appendage also forms as a conical outgrowth from the dorsomedial surface of each otocyst, and the mesenchyme around the otocyst begins to condense to form the otic capsule at this time. The otic vesicle enlarges and its walls show differential thickening during stage 14. In addition, the elongating endolymphatic diverticulum becomes set off from the future utricular portion of the otic vesicle by the developing utriculo-endolymphatic fold. The cochlear and vestibular pouches are distinct and the cochlear and vestibular ganglia as well as the vestibulocochlear nerve form at stage 15. The differential thinning of the walls of the otocyst presage the appearance of the semicircular canals, while the endolymphatic diverticulum continues to elongate during stage 16. The primordia of both the superior and caudal semicircular ducts appear in stage 17 and 1-3 semicircular ducts are differentiated by stage 18. The slender, ventral portion of the otic vesicle differentiates into the cochlear duct, which is L-shaped, just prior to stage 19. The duct subsequently changes rapidly by extensive lengthening and progressive spiralling such that it approaches 2.5 turns by stage 23.
Nose/palate (stages 12-23)
The olfactory or nasal placodes are first evident in stage 12, and appear as ectodermal thickenings on the ventrolateral surfaces of the head by stage 13. The placodes become thickened and begin to invaginate to form nasal pits during stage 14. The nasal pits are widely separated on the frontal surface of the head and are bordered by the medial and lateral nasal processes during stage 15. In stage 16 embryos, the maxillary process has developed cranially and contributes to the ventrolateral margin of the nasal pit. The epithelium separating the mesenchyme of the maxillary and medial nasal processes forms the nasal fin which is continuous, cranially with the epithelium lining the nasal pit, and caudally with the epithelium lining the roof of the developing oral cavity. The nasal fins expand during stage 17 and then degenerate as the primary palate is formed during the subsequent stage. Olfactory nerve fibres also appear along the craniomedial aspect of the primary nasal cavity and pass toward the telencephalon during stage 17.
By stage 18, the primary palate has formed as a continuous bridge of mesenchyme extending laterally from the midline area that is caudal to the developing nasal septum to the maxillary process mesenchyme. The bucconasal membrane at the caudal edge of the primary palate separates the blind end of the primary nasal cavity from the bucconasal cavity. The primordium of the nasal septum cartilage appears as a condensation of mesenchymal cells in the area between the primary nasal cavities. The bucconasal membrane ruptures at stage 19, allowing the nasal sac to communicate with the oral cavity through the primitive choana. The lateral palatine processes are blunted and project medially, maintaining a close association with the lateral surface of the tongue. The anlage of the nasal capsule appears as a mesenchymal condensation lateral to the developing conchae and maxillary osteoblasts can be identified rostral to the primitive choana. Although the palatine processes lengthen, little change occurs in their orientation during stages 20 and 21. The area of maxillary osteoblasts increases in size and differentiation of chondroblasts is apparent in the nasal septum area in stage 20 embryos. By stage 21, cartilage formation is readily apparent in the nasal septum and premaxillary and maxillary bone formation can be distinguished. The middle portion of the lateral palatine processes undergoes considerable medial rotation, which gives the appearance of lifting the tongue by stage 22. In the subsequent stage (23), the rostral two-thirds of these processes has moved to a horizontal position above the tongue, and the epithelia that separate them from each other and from the nasal septum have fused and are degenerating. The lower jaw is depressed and the tongue appears Table I. to be contracted, which may facilitate the removal of the tongue from its earlier position between the processes. At the ossification centre of the palatine bone, the processes are in a state of transformation from a vertical to a horizontal position. Soft palate formation in the midline is not yet complete.
Comparative features
Baboon embryos vary by approximately 2-3 days in age for each developmental stage during organogenesis (stages 8-23; Figure 3A ). In contrast, greatest or crown-rump length (mm) is much more variable between the stages ( Figure 3B) ; variation is greatest in stages 11, 17, 18, 21 and 23. Differences in length at stage 11 can be explained, in part, by the degree of the cephalic flexure. Embryonic development has been studied extensively in the rhesus and the cynomolgus monkeys (Macaca mulatta and M. fascicularis), as well as in the baboon. Developmental stages 10-23 are virtually identical with regard to time and external characteristics in these macaque species and baboons ( Figure 4A ) (Hendrickx, 1971a; Hendrickx and Cukierski, 1987; Geijsberts, 1981, 1985) . On the other hand, during stages 8-12, human embryos are slightly younger than nonhuman primate embryos. By stage 14, this situation is reversed and human embryos are several days older than nonhuman primate embryos ( Figure 4A ). This divergence continues throughout the remainder of organogenesis: stage 23 human embryos are approximately 6-8 days older than their nonhuman counterparts. The length of both human and nonhuman primate embryos studied was similar, except for the increased length in human embryos noted for stages 21-23 ( Figure 4B ). Makori et al. (1996) ; c d O'Rahilly and Müller (1987, 1994) .
The development of the brain and its derivatives in the baboon (Hendrickx, 1971a ) from stages 8 through 16 closely corresponds to that described for humans (Gasser, 1975; O'Rahilly and Müller, 1994) , the rhesus monkey Gribnau and Geijsberts, 1981) and the cynomolgus monkey (Makori et al., 1996) . These similarities mainly relate to the chronological order of differentiation of specific structures of the developing brain, although their appearance may differ slightly in terms of the stage of the embryos in which they appear (Table II) . The overall similarity to humans in the characteristics of early brain development indicates that the baboon, in addition to the macaques, would serve as a suitable animal model for further studies of normal and abnormal neurological development. These observations also emphasize the importance of using embryonic stage rather than embryonic age in any comparative studies involving the central nervous system (CNS) and other embryonic organ systems in these species.
Spontaneous incidence of prenatal loss
Prenatal loss represents failure of the maternal-fetal-placental unit to maintain a normal relationship due to a variety of endogenous or environmental factors. The incidences of abortion [gestational day (GD) <140] and stillbirth (GD ≥140) reported for one baboon colony over an 8 year period were 3.9% (14/357) and 11.2% (40/357) respectively (Hendrickx, 1966) . The frequency of loss during the period of organogenesis (~GD 20-50) in the baboon was relatively low, i.e. 2.4% (3/122) in another colony (Hendrickx and Binkerd, 1980) . Slightly higher rates have been reported more recently for rhesus and cynomolgus monkeys (Hendrie et al., 1996) . Embryonic death rates during organogenesis were 5.1% (68/1332) and 9.2% (42/455) for the rhesus and cynomolgus monkey respectively. The incidences of total prenatal loss throughout gestation for each species were 17% (226/1332) for the rhesus monkey and 17.8% (81/455) for the cynomolgus monkey.
Teratology
A primary objective of experimental teratology is to determine potential adverse effects of chemicals and other environmental agents on development prior to widespread human exposure. Since ethical considerations prohibit the testing of compounds for teratogenicity in the human population, we must make extrapolations of potential human risk from data obtained in experimental species. The use of nonhuman primates in this capacity has been advocated on the basis of their phylogenetic relatedness to humans, as reflected in anatomical, reproductive and embryological similarities. Testing agents in nonhuman primates has involved recognition of the teratological principles outlined by Wilson (1973) , which include sensitive periods, doseresponse relationships, maternal toxicity, as well as the various manifestations of deviant development (death, malformation, growth retardation and functional deficit). Appropriate protocols have been developed and utilized in safety evaluation of new chemicals, drugs and biotechnology products. In addition to risk assessment, nonhuman primates have been used as models for basic studies of congenital malformations. These models have contributed valuable information regarding the morphological characterization as well as the pathogenesis of a number of human malformation syndromes. The contribution that the baboon has made to both of these areas of experimental teratology is summarized below.
Thalidomide
The potential value of nonhuman primates as models for human responses in early development and safety assessment of drugs and chemicals in pregnancy was not realized until the thalidomide disaster of the late 1950s and early 1960s. This drug, commonly prescribed for morning sickness associated with early pregnancy, was subsequently associated with a syndrome of malformations involving the limbs (amelia, phocomelia), external ears, heart and kidney in exposed infants (Lenz, 1961; McBride, 1961) . Initial studies clearly demonstrated the similarity in response to thalidomide in human, macaque and baboon embryos in three main areas: the sensitive period, the pattern of malformations and the lowest effective dose required to induce a developmentally toxic response.
In a relatively large series of experiments involving single and multiple dose treatments from 4 to 24 mg/kg/ day, a sensitive period between days 25-29 of gestation was defined for the baboon Hendrickx, 1971b) . Macaque species have also demonstrated a similar sensitive period to thalidomide. A cranio-caudal gradient of development was also evident, in that treatment on day 25 most commonly affected the upper limbs, treatment on day 27 affected the lower limbs, and treatment on day 29 only affected the tail. Limb reduction defects, including amelia and phocomelia, were the most common observation in macaques as well as in baboons ( Figure 5 ). However, isolated cases of polydactylism, which is a multiplication defect, were also observed.
Sex hormones
Sex steroidal hormones have been used singly and in combination for a variety of clinical purposes world-wide as oral contraceptives, oral pregnancy tests, treatment for habitual or threatened abortion and antineoplastic therapy. Common hormonal agents used for purposes of pregnancy detection consisted of a combination of either the natural or synthetic oestrogens and progesterone. Although pregnancy tests involving steroidal hormones are not currently used, similar combinations, especially the synthetic forms, are still used for purposes of contraception. Concern about possible harmful effects of sex hormones has existed since their introduction and reports of their adverse effects on the genitalia of the developing fetus first appeared in the 1950s (Wilkins et al., 1958; Wilkins, 1960) . Subsequently, a large body of literature has been accumulated and extensively reviewed (Schardein, 1980; Wilson and Brent, 1981; Wiseman and Dodds-Smith, 1984; Katz et al., 1985) The main objectives of these reviews were threefold: (i) to determine whether the observed defects were genital (i.e. target tissue) or nongenital malformations; (ii) to identify the hormones by their chemical nature (steroidal or nonsteroidal, synthetic versus natural) or by biological activity (oestrogenic, progestational, androgenic) and (iii) to correlate outcome with agents used singly or in combination. These studies showed that alterations in development of the external genitalia resulted only from administration in utero of hormones which were heterologous to the female genetic sex. Clitoral hypertrophy, labial fusion and increased anogenital distances were observed following exposure to such hormones with androgenic properties.
Comparative studies were done in the baboon and rhesus and cynomolgus monkeys to determine the potential embryotoxicity of the combination of norethisterone acetate (NEA) and ethinyl oestradiol (EE). The pregnant females of all three species received daily oral doses that ranged from 1 to 1000 times the human dose equivalent (HDE) from day 20 to day 50 of gestation (NEA and EE: human dose 0.2 mg + 0.0004 mg/kg). This regimen, encompassing the period of organogenesis, was chosen to evaluate teratogenicity associated with clinical use of the drug, i.e. one tablet taken orally on consecutive days during early suspected pregnancy.
Embryo lethality was the primary outcome of treatment in all three species. While there was no clear-cut dose dependency, it appeared that the critical dosage level for embryotoxicity was 100× HDE. The time during which the pregnancy losses occurred was also similar for all three species. Maternal toxicity was only seen in the cynomolgus monkey at the highest doses. In addition to embryo lethality, various forms of masculinization, including clitoral enlargement, increased anogenital distance and reduced vaginal opening, represented pertubations of the hormonetarget organ relationship. The masculinization effects were seen only at extremely high doses, i.e. 300× and 1000× the HDE, clearly suggesting a wide margin of safety for these drugs.
Medroxyprogesterone acetate (MPA; Depo-Provera), a long-acting injectable synthetic progestin used as a contraceptive by 1.2-2.5 million woman world-wide, was also studied in baboons to determine its embryotoxic effects (Tarara, 1984; Prahalada et al., 1985a,b) . A single dose of MPA was administered i.m. on day 27 of gestation at three different doses. The dosage corresponded to 1 (2.5 mg/kg), 10 (25 mg/kg) and 40 (100 mg/kg) times the HDE. MPA was not teratogenic or embryolethal at 1× HDE. The teratogenicity was confined to the higher doses and was limited to malformations of the external genitalia of both male and female fetuses at 10× and 40× HDE and adrenal hypoplasia at 40× HDE (Figure 6 ). These abnormalities in MPA-exposed fetal baboons were categorized as 'target organ' effects of an administered sex hormone. Non-target organ abnormalities (i.e. heart or limb defects) were not present in any of the fetuses examined. Embryo lethality was not increased at the two lower doses; however, one-half of the pregnancies at 40× HDE aborted prior to day 100 of gestation.
The maternal serum MPA concentrations, which were high during the critical period of adrenal and genital development, partially explained the severity of malformations in fetuses exposed to the two highest doses. However, the paradoxical effects observed in male and female baboon fetuses were poorly understood. Various possible mechan-isms that can lead to masculinization of females and/or feminization of males have been discussed in detail elsewhere (Prahalada et al., 1985a,b) . Female pseudohermaphroditism is known to occur following maternal ingestion of androgens or synthetic progestational agents during external genital differentiation (Grumbach et al., 1959 (Grumbach et al., , 1960 . The decrease in adrenal weight observed at the high dose in baboons was attributed to the glucocorticoid activity of MPA. Nonhuman primate fetuses have a well-developed fetal adrenal zone which responds to the stimulating effects of adrenocorticotrophic hormone (ACTH), as in human fetuses.
Collectively, these studies in baboons and macaques showed that the primary manifestation of embryotoxicity following exposure to combined sex steroids as well as a synthetic progestin during early pregnancy was embryonic or fetal death in the absence of nongenital teratogenicity. These results support epidemiological and laboratory data which indicate that there is no clear association between sex steroid exposure in utero and nongenital teratogenicity.
Triamcinolone acetonide
Corticosteroids have been extensively used as teratogenic agents for many years to study cleft palate and related craniofacial defects . The human data concerning teratogenicity of corticosteroids are equivocal and they are generally considered to lack teratogenicity. Triamcinolone acetonide (TAC) is the only corticosteroid that has been studied during the embryonic period in nonhuman primates . This study consisted of a comparison of craniofacial and brain defects in the baboon, rhesus monkey and the bonnet monkey after exposure to various doses of TAC (5-20 mg/kg) administered on single or multiple days between GD 23 and 31. The TAC sensitive period (GD 23-31) for brain and craniofacial defects encompasses neural tube closure, formation of the primary divisions of the brain (forebrain, midbrain and hindbrain) and early formation of pharyngeal arches, which are major contributors to the face and head. The pattern of malformations was essentially the same in all these species and was similar following singleand multiple-day treatments, with the principal difference being an increased severity of the defects following multiple-day treatments. The CNS and cranium were the most commonly malformed areas in all three species. Intrauterine growth retardation, as well as increased prenatal mortality, were also observed in these studies .
Cranium bifidum, associated with encephalocele, meningocele and, less frequently, hydrocephalus, was a commonly observed skeletal defect in the multiple-dose treatment groups (Figure 7) . Cranium bifidum occultum, in association with aplasia cutis congenita or in the absence of any exterior gross lesions, was more frequently observed in cases treated for a single day. The calvarial bones were characterized by an underossification of the frontal, parietal and occipital bones, with a thin membranous tissue (dense fibrous connective tissue) covering the unossified areas. The underossification was most apparent at the midline and involved the metopic, sagittal, coronal and lambdoid sutures. Abnormalities of the cranial base were also observed, mainly affecting the occipital, frontal and sphenoid bones.
A variety of facial abnormalities, described collectively as craniofacial dysmorphia, were seen in all three species. These were frequently accompanied by cleft or arched palate, with arched palate being much more frequent ( Figure  7 ). In addition to the encephaloceles and hydrocephalus discussed earlier, a number of cerebellar and midbrain defects were described. Minor malformations of the skeleton and viscera were also observed, including scoliosis and kinked tail. The effects of TAC (3-28 mg/kg) administered for 1-4 consecutive days during later periods of development (i.e. GD 37-48, during the time of palate closure) included resorption, abortion and growth retardation, as well as defects of the craniofacial region, chest (funnel chest; Figure 7 ), lower limbs and thymus . A larger portion of the rhesus and bonnet monkeys had craniofacial defects than did the baboon fetuses, probably because the doses used in the baboon were somewhat lower than those administered to the macaques.
From these studies it was concluded that the baboon and rhesus and bonnet monkeys responded to the teratogenic and developmental toxic effects of TAC in a similar manner, each displaying the major features of the malformation syndrome. The ability to induce meningoencephalocele consistently in the nonhuman primate, which is a suitable model for human neural development, may also aid in clarifying the pathogenesis of this defect and other CNS lesions (Hendrickx and Tarara, 1990) .
Bendectin
Bendectin (doxylamine succinate and pyridoxine hydrochloride) was a widely prescribed drug for the treatment of nausea and vomiting in pregnancy before 1983, when the manufacturers voluntarily ceased production; the drug remains on the market in Canada. It was the only antiemetic drug specifically approved for use during pregnancy by the Food and Drug Administration. Because of the increasing notoriety over the possibility of adverse effects from the use of Bendectin during human pregnancy, studies were carried out in baboons and rhesus and cynomolgus monkeys to ascertain the developmental toxicity of this antinauseant during early pregnancy, the most likely time for pregnant women to experience nausea and to be prescribed the drug (Brent, 1983; Cordero and Oakley, 1983; Kalter and Warkany, 1983; Hendrickx et al., 1985a,b) .
Previous studies in rodents and rabbits reported no increase in embryotoxicity following exposure in utero to Bendectin (Scott, 1984) .
Pulverized Bendectin tablets, each containing 10 mg of doxylamine succinate and 10 mg of pyridoxine hydrochloride, were administered orally to all three species. Decapryn, containing 10 mg of doxylamine succinate, was also used in baboons as a substitute for Bendectin in order to reduce the total amount of the drug orally administered to these somewhat intractable animals. Bendectin was administered daily from days 22 to 50 of pregnancy in all three species. Dosages of 10×, 20× and 40× HDE (0.667 mg/kg/ day based on a 60 kg woman taking four tablets/day) were used in the rhesus and cynomolgus monkeys and 1× and 10× HDE in the baboon. Decapryn was given at 10× HDE (also 0.667 mg/kg/day). Fetal examinations were performed during mid-gestation (GD 100) and at term .
Bendectin exposure during organogenesis resulted in an isolated defect of the heart, interventricular septal defect (VSD), which involved an abnormal communication of the left and right ventricle following fetal examinations at GD 100 . No interventricular septal defects, or any other defects, were found following examinations at term . These data clearly suggested that Bendectin caused a delay in formation of the muscular interventricular septum that was spontaneously corrected with further development, resulting in a normal heart rate at birth. No significant differences in VSD were observed for the different doses in any of the three species. The majority of the cases of VSD involved the muscular portion of the interventricular septum: approximately one-half of the fetuses had defects in the smooth portion of the septum and one-half had defects in the trabecular portion (Figure 8 ; Hendrickx et al., 1985a) . One fetus, a baboon, had multiple defects involving the face, hands and genitalia, in addition to heart defects. This malformed case was considered unrelated to treatment because similar defects were not observed in macaques at higher doses (i.e. lack of a dose response) and because of the isolated nature of the non-cardiac defects (see the section Spontaneous Malformation). The incidence of abortion (prenatal death) was within background rates for each species (Hendrie et al., 1996; Hendrickx and Binkerd, 1980) .
The natural history of VSD in humans is well documented and shows that large defects require surgical correction, while many VSD will reduce in size with age and small defects will close spontaneously with no further treatment. The rate of closure is ~30% within the first year of life and as high as 50% within 10 years. The specific nature of VSD in Bendectin-treated baboons and macaques makes it an excellent candidate for the study of pathogenesis of VSD formation and the mechanism of spontaneous closure of the defect.
The results of human epidemiological studies on the association of Bendectin with cardiac malformations have been equivocal, showing either a slight (Rothman et al., 1979) or no (Mitchell et al., 1981) association. If Bendectin were to induce VSD in humans in a similar fashion to that reported in prenatal nonhuman primates, one would expect that the vast majority of defects would close prior to birth. The small number that might persist to term would be difficult, if not impossible, to separate from the background rate of spontaneous defects. The incidence of VSD in the USA has risen threefold since the early 1970s. If Bendectin use were a significant factor in this increase, one would expect a sharp decrease in the number of reported VSD beginning several months after June 1983, when the drug ceased to be manufactured, and as women who were currently on Bendectin treatment completed their pregnancies.
Rubella virus
The initial definition of the rubella syndrome, the first human teratogen to be recognized, consisted of congenital heart disease, deafness and cataracts (Gregg, 1941) . The constellation of defects has been expanded to include growth retardation, encephalitis, thrombocytopenia, radiographic changes in long bones and persistence of virus postnatally (Shepard, 1986) . The teratogenic effects of the rubella virus have been studied in the baboon and cynomolgus monkey (Hendrickx, 1966; Delahunt, 1966) . Preliminary experiments to determine the effects of the rubella virus during organogenesis demonstrated a high incidence of abortion , stillbirths and early postnatal death. No other abnormalities were noted. Cataracts were induced in the cynomolgus monkey by exposure of the conceptus to the virus in early pregnancy. The combined effects observed in these two primate species only partially mimic the human syndrome, characterized by prenatal loss, growth retardation and malformations, including eye defects, heart disease and deafness. These results were due, in part, to the inability to determine accurately viral titres at the time of the nonhuman primate experiments.
Comparative features
Table III summarizes the results of teratology studies carried out in baboons and comparative information in humans and macaques. Overall, the presence/absence of malformations in nonhuman primate studies has generally reflected the situation in humans as derived from epidemiological studies and case reports. The exception to this trend is the lack of concordance, particularly in baboon, with the rubella virus syndrome reported in human infants. As mentioned previously, this may be due to the preliminary nature of these nonhuman primate studies. As indicated in Table III , there is also some consistency in the occurrence of death/abortion and growth retardation between macaques and baboons for the agents listed. Lack of adequate information on these two endpoints in humans prevents meaningful comparisons for all of these compounds.
Protocols for safety evaluation
With the development and subsequent safety evaluation of biotechnology products, the role of nonhuman primates has changed from that of an alternate test species to that of a preferred or essential test subject because many of these products are bioactive only in species phylogenetically and physiologically close to man (Henck et al., 1996) . In standard teratology studies in both baboons and macaques, females are inseminated in the ovulatory phase of the men-strual cycle, and pregnancy confirmation is performed between GD 18 and 20 using an assay for either serum or urine chorionic gonadotrophin and progesterone and/or ultrasound. In the studies performed to date, treatment with the test article on varying schedules (daily, weekly) encompasses the entire period of organogenesis and may be extended for 20 or 30 additional days into the fetal period (Figure 9 ). Under some conditions of testing, shorter treatment periods of 1-15 days at various times during organogenesis may be preferred due to the chemical or physical characteristics of the test substance (Wilson, 1973) . A Caesarean section is usually performed on GD 100, approximately two-thirds of the way through the 165-day gestation period for rhesus and cynomolgus macaques and the 175-day gestation period for baboons. Numerous studies have demonstrated that satisfactory anatomical evaluation for external, skeletal and visceral malformations, as well as for growth retardation, can be performed at this time point. A variety of maternal endpoints have been studied and may include clinical signs, body temperature, haematology and blood pressure. 
Spontaneous malformations
The first known report on spontaneous congenital malformations in baboons was provided by Lapin and Yakovleva (1963) for the large colony in Sukhumi, Georgia of the former USSR (Table IV) . They reported a combined incidence of 0.48% for baboons (multiple species) and rhesus monkeys. A similar incidence (0.53%) was found in the Southwest Foundation Colony (San Antonio, TX, USA). The two malformations, congenital blindness at birth and left diaphragmatic hernia in a 14-week old fetus, were observed in 375 cases. Data obtained from necropsy cases at the California Regional Primate Research Center (CRPRC), Davis, USA between 1969 and 1982 indicated only one case of VSD in 61 cases reviewed (1.6%) (Hendrickx and Prahalada, 1986 ). Additional spontaneous defects in various species of baboon reported in the literature are summarized in Table V . In contrast to these malformations, which primarily affect one organ system, was the case of multiple defects that was observed in one of the baboon teratology studies at the CRPRC following exposure to Bendectin. Due to the isolated nature of the malformation; i.e. lack of dose relationship, and the lack of a biologically plausible mechanism for teratogenicity, this case was considered spontaneous or due to unknown causes, rather than a drug-induced abnormality. The overall incidence of <1% malformations in baboons is similar to that reported for other commonly used primates (Hendrickx, 1966; Hendrickx and Prahalada, 1986; Peterson et al., 1997) . In summary, studies conducted over the past 30 years have clearly demonstrated the contribution that the baboon, as a surrogate simian model, has made to our understanding of both normal and abnormal embryonic development. The many similarities shared with early human pregnancy have enabled direct comparisons with known human teratogens and provided a valuable model for screening new drugs/chemicals prior to human exposure. Pruzansky (1975) Unilateral renal aplasia (1) Kim and Kalter (1972) Diaphragmatic hernia (1) Hendrickx and Gasser (1967) Papio anubis Male pseudohermaphroditism (1) Wadsworth et al. (1978) Unilateral renal aplasia (1) McCraw et al. (1973) Papio cynocephalus Supernumerary nipple (1) Buss and Hamner (1971) Papio doguera Coloboma (2) Schmidt (1971) Papio hamadryas Arnold-Chiari malformation (1) Cameron and Hill (1955) Patent ductus arteriosus, aortic hypoplasia, arotic and pulmonary valvular deformities (1) Ventricular septal defect, overriding aorta, aortic and pulmonic stenosis (1) Ventricular septal defect, mitral and tricuspid valvular deformities, left ventricular hypoplasia (1) Krilova and Yakovleva (1972) Papio sphinx Hand anomaly (1) Schultz (1944) Papio ursinus XY gonadal dysgenesis (1) Bielert et al. (1980) Retrocaval right ureter (1) Hesse (1969) Pygathrix nemaeus Pectus excavatum (1) Sedgwick (1981) 
